New drug makes you twitch
Stock Market News and Investment Information | Reuters.com: "Pozen Inc. will argue to U.S. advisers that its experimental migraine treatment MT 100 poses little risk of an unusual side effect that causes involuntary facial and tongue movements.
Regulators rejected the drug in May 2004, citing concerns about its effectiveness and the chances of a potentially permanent movement disorder called tardive dyskinesia (TD).
MT 100 combines the pain-relieving ingredient naproxen with another medicine, metoclopramide, that is sold for treating migraines and acid reflux. Metoclopramide has been associated with TD, which causes involuntary, repetitive movements of the mouth and tongue such as grimacing or lip-smacking."
My Take:
You gotta love these drug companies. Now they've found a way to take your money and make you look like a fool in the process!
Regulators rejected the drug in May 2004, citing concerns about its effectiveness and the chances of a potentially permanent movement disorder called tardive dyskinesia (TD).
MT 100 combines the pain-relieving ingredient naproxen with another medicine, metoclopramide, that is sold for treating migraines and acid reflux. Metoclopramide has been associated with TD, which causes involuntary, repetitive movements of the mouth and tongue such as grimacing or lip-smacking."
My Take:
You gotta love these drug companies. Now they've found a way to take your money and make you look like a fool in the process!
posted by Ron King at 9:12 PM
0 Comments:
Post a Comment
<< Home